Vargas, Claudia
Burgos, Felip
Cano Franco, Isaac
Blanco Vich, Isabel
Caminal, Pere
Escarrabill Sanglas, Joan
Gallego, Carles
Llauger, M. Antonia
Miralles Barrachina, Felip
Solans, Oscar
Vallverdú, Montserrat
Velickovski, Filip
Roca Torrent, Josep
2016-07-11T10:17:33Z
2016-07-11T10:17:33Z
2016-06-02
2016-07-11T10:17:38Z
The potential of forced spirometry (FS) testing for diagnosis, monitoring and management of chronic respiratory patients is well established1-3 such that FS is a pivotal test in both respiratory medicine and primary care. Moreover, it also shows potential in the informal care scenario: that is, in pharmacy offices for case-finding purposes4,5 and for self-management in selected patients.6,7 We acknowledge that well-designed studies8 have failed to show practical benefits of FS for asthma and COPD diagnosis and management in primary care. However, it has been demonstrated that historical limitations for extensive use of FS in primary care, because of suboptimal quality of testing, can be overcome by offline remote support by specialised professionals.9,10 Large-scale deployment of this type of setting has generated evidence of cost-effectiveness..
English
Malalties pulmonars obstructives cròniques; Asma; Diagnòstic; Atenció primària; Assaigs clínics; Chronic obstructive pulmonary diseases; Asthma; Diagnosis; Primary health care; Clinical trials
Nature Publishing Group
Reproducció del document publicat a: http://dx.doi.org/10.1038/npjpcrm.2016.24
npj Primary Care Respiratory Medicine, 2016, vol. 26, p. 16024
http://dx.doi.org/10.1038/npjpcrm.2016.24
cc-by (c) Vargas, C. et al., 2016
http://creativecommons.org/licenses/by/3.0/es